including, but not limited to assumptions, beliefs
and opinions relating to the business and growth strategy of VirtualHealth
Technologies, Inc. and its wholly owned subsidiaries Verified Prescription
Safeguards, Inc., VPS Holding, LLC, Envoii Healthcare, LLC, Medical Office
Software, Inc. and implementation thereof, based upon the Company's
interpretation and analysis of financial and market conditions, the decisions
of businesses with whom the Company is either engaged in business with or
negotiating, healthcare industry trends and management's ability to
successfully finance, develop, market, sell and implement its e-commerce and
internet solutions, clinical and financial e-transaction services and software
applications to physicians, pharmacies, governmental agencies, laboratories,
insurance companies, HMOs, and payers. These factors and other risk factors
are more fully discussed in the Company's filings with the Securities and
Exchange Commission. The Company expressly disclaims any intent or obligation
to update any forward-looking statements.
Contact: Shareholder Relations
VirtualHealth Technologies, Inc.
325 West Main Street, Suite 240
Lexington, KY 40507
(859) 455-9255
Email: Shareholder.Relations@virtualhealthtechnologies.com
Website: www.virtualhealthtechnologies.com
'/>"/>SOURCE VirtualHealth Technologies, Inc. Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 2 Related medicine news :1.
VirtualHealth Technologies, Inc. Announces Management Appointment2.
VirtualHealth Technologies, Inc., Announces Its Associate, Private Access, Appoints Marc Kirshbaum as President & COO3.
VirtualHealth Technologies, Inc., Announces That Its Associate, Private Access, Will Be Partnering with Genetic Alliance To Accelerate Medical Research While Protecting Privacy4.
VirtualHealth Technologies CEO Scott Hare Discusses New Security and Encryption Technologies for Healthcare Sector with CEORoadshow.com in Exclusive Online Audio Interview5.
ReBuilder Medical Technologies, Inc. Reports International Sales Expansion6.
ReBuilder Medical Technologies, Inc. Signs Agreement for Distribution in Maine7.
MedCom USAs Subsidiary Card Activation Technologies, Inc.s SB2 Registration Declared Effective by SEC8.
Neurobiological Technologies, Inc. Announces Receipt of Determination Letter from NASDAQ9.
ReBuilder Medical Technologies, Inc. Increases Staffing by 30% in Three Weeks Due to Increase in Demand for All ReBuilder Medical Products10.
ReBuilder Medical Technologies, Inc. Reports Monthly Sales in 2007 Nearly Doubling Monthly Sales in 2006, Including Record Daily Sales in September 200711.
ReBuilder Medical Technologies, Inc. Contracts with ETS to Manufacture the Newest Version of its ReBuilder Neuropathy Treatment Device; Expects Sales to Increase 30%